# Tranexamic Acid for the Prevention of Blood Loss in High Risk Delivered Women

> **NCT04201951** · NA · COMPLETED · sponsor: **Hawler Medical University** · enrollment: 196 (actual)

## Conditions studied

- Postpartum Hemorrhage
- High Risk Pregnancy
- Tranexamic Acid
- Third-Stage Postpartum Hemorrhage, With Delivery

## Interventions

- **DRUG:** Tranexamic acid injection
- **OTHER:** Glucose water 5%

## Key facts

- **NCT ID:** NCT04201951
- **Lead sponsor:** Hawler Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-01
- **Primary completion:** 2020-10-10
- **Final completion:** 2020-10-10
- **Target enrollment:** 196 (ACTUAL)
- **Last updated:** 2020-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04201951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04201951, "Tranexamic Acid for the Prevention of Blood Loss in High Risk Delivered Women". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04201951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*